| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
July 20, 2022
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate...
-
May 31, 2022
Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and...
-
March 15, 2022
O acordo de distribuição global com a Saladax Biomedical disponibiliza ensaios de monitorização de medicamentos terapêuticos antipsicóticos aos clientes da Beckman Coulter Lisboa, 15 de...
-
March 15, 2022
L’accordo con Saladax Biomedical per la distribuzione a livello mondiale porterà i test di monitoraggio per i farmaci terapeutici antipsicotici ai clienti Beckman Coulter Milano, 15 marzo 2022...
-
March 15, 2022
L'accord de distribution mondiale conclu avec Saladax Biomedical permet aux clients de Beckman Coulter d'accéder aux tests. PARIS, FRANCE, le 15 mars 2022 — Beckman Coulter, l’un des leaders...
-
March 15, 2022
Un acuerdo de distribución global con Saladax Biomedical pone a disposición de los laboratorios y profesionales sanitarios pruebas de monitorización de medicamentos antipsicóticos. Esta tecnologí
-
March 15, 2022
Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter customers BREA, Calif. , March 15, 2022 /PRNewswire/ -- Beckman...
-
March 15, 2022
Durch die globale Vertriebsvereinbarung mit Saladax Biomedical stehen den Kunden von Beckman Coulter Tests zur Überwachung therapeutisch eingesetzter antipsychotischer Medikamente zur Verfügung. Mü
September 28, 2021Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines...
-
July 26, 2021
Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture,...
May 19, 2021Beckman Coulter, a global clinical diagnostics leader, today announced the launch of Access SARS-CoV-2 IgG (1st IS), a fully-quantitative lab-based Immunoglobulin G (IgG) serology test that...
May 4, 2021Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than...
March 23, 2021Beckman Coulter, a clinical diagnostics leader, today announced that its Access SARS-CoV-2 IgG II antibody assay received U.S. Emergency Use Authorization (EUA) from the U.S. Food and Drug...
March 18, 2021Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their...
January 25, 2021Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to...
December 18, 2020Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen...
-
November 23, 2020
Beckman Coulter, a clinical diagnostics leader, today launched its Access SARS-CoV-2 IgG II assay that measures a patient's relative level of antibodies in response to a previous SARS-CoV-2...
- November 10, 2020
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test...
October 15, 2020Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the...
October 9, 2020Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
October 6, 2020Beckman Coulter, a clinical diagnostics leader, today announced research results that demonstrate its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate...
October 1, 2020Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a...
August 24, 2020Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test demonstrated 99.9% specificity against...
August 5, 2020Beckman Coulter today announced new analysis from the pivotal study of its novel monocyte distribution width (MDW) hematologic biomarker for sepsis detection. The analysis showed that abnormal MDW...
July 23, 2020Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have...
